vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and First Western Financial Inc (MYFW). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $27.5M, roughly 1.7× First Western Financial Inc). Over the past eight quarters, First Western Financial Inc's revenue compounded faster (10.0% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
The Western Union Company is an American multinational financial services corporation headquartered in Denver, Colorado.
IRWD vs MYFW — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $27.5M |
| Net Profit | $-2.3M | — |
| Gross Margin | — | — |
| Operating Margin | 14.3% | — |
| Net Margin | -4.8% | — |
| Revenue YoY | -47.3% | — |
| Net Profit YoY | -200.9% | — |
| EPS (diluted) | $0.01 | $0.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $27.5M | ||
| Q4 25 | $47.7M | $26.7M | ||
| Q3 25 | $122.1M | $26.3M | ||
| Q2 25 | $85.2M | $24.2M | ||
| Q1 25 | $41.1M | $24.8M | ||
| Q4 24 | $90.5M | $24.3M | ||
| Q3 24 | $91.6M | $22.5M | ||
| Q2 24 | $94.4M | $22.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.3M | $3.3M | ||
| Q3 25 | $40.1M | $3.2M | ||
| Q2 25 | $23.6M | $2.5M | ||
| Q1 25 | $-37.4M | $4.2M | ||
| Q4 24 | $2.3M | $2.7M | ||
| Q3 24 | $3.6M | $2.1M | ||
| Q2 24 | $-860.0K | $1.1M |
| Q1 26 | — | — | ||
| Q4 25 | 14.3% | 16.6% | ||
| Q3 25 | 61.8% | 15.1% | ||
| Q2 25 | 53.2% | 13.7% | ||
| Q1 25 | -70.7% | 21.6% | ||
| Q4 24 | 34.8% | 16.1% | ||
| Q3 24 | 28.0% | 11.9% | ||
| Q2 24 | 26.5% | 6.2% |
| Q1 26 | — | — | ||
| Q4 25 | -4.8% | 12.9% | ||
| Q3 25 | 32.8% | 12.1% | ||
| Q2 25 | 27.7% | 10.3% | ||
| Q1 25 | -90.9% | 16.9% | ||
| Q4 24 | 2.5% | 11.3% | ||
| Q3 24 | 4.0% | 9.5% | ||
| Q2 24 | -0.9% | 4.7% |
| Q1 26 | — | $0.63 | ||
| Q4 25 | $0.01 | $0.33 | ||
| Q3 25 | $0.23 | $0.32 | ||
| Q2 25 | $0.14 | $0.26 | ||
| Q1 25 | $-0.23 | $0.43 | ||
| Q4 24 | $0.03 | $0.28 | ||
| Q3 24 | $0.02 | $0.22 | ||
| Q2 24 | $-0.01 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $273.4M |
| Total Assets | $396.9M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | $0 | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — |
| Q1 26 | — | $273.4M | ||
| Q4 25 | $-261.8M | $265.6M | ||
| Q3 25 | $-264.2M | $261.5M | ||
| Q2 25 | $-308.2M | $258.8M | ||
| Q1 25 | $-334.1M | $256.6M | ||
| Q4 24 | $-301.3M | $252.3M | ||
| Q3 24 | $-311.3M | $248.8M | ||
| Q2 24 | $-321.7M | $246.9M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | $396.9M | $3.2B | ||
| Q3 25 | $396.1M | $3.2B | ||
| Q2 25 | $342.9M | $3.0B | ||
| Q1 25 | $327.2M | $2.9B | ||
| Q4 24 | $350.9M | $2.9B | ||
| Q3 24 | $389.5M | $2.9B | ||
| Q2 24 | $395.6M | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | — |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $-1.8M | ||
| Q3 25 | $47.6M | $10.0M | ||
| Q2 25 | $-15.1M | $-9.1M | ||
| Q1 25 | $20.0M | $8.0M | ||
| Q4 24 | $15.2M | $606.0K | ||
| Q3 24 | $9.9M | $18.8M | ||
| Q2 24 | $33.5M | $-11.5M |
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | $-5.8M | ||
| Q3 25 | $47.6M | $9.0M | ||
| Q2 25 | $-15.1M | $-9.7M | ||
| Q1 25 | $19.9M | $7.0M | ||
| Q4 24 | — | $-607.0K | ||
| Q3 24 | $9.9M | $18.6M | ||
| Q2 24 | $33.4M | $-11.9M |
| Q1 26 | — | — | ||
| Q4 25 | 156.3% | -21.6% | ||
| Q3 25 | 39.0% | 34.1% | ||
| Q2 25 | -17.7% | -39.9% | ||
| Q1 25 | 48.4% | 28.1% | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | 10.8% | 82.3% | ||
| Q2 24 | 35.4% | -52.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 14.9% | ||
| Q3 25 | 0.0% | 4.1% | ||
| Q2 25 | 0.0% | 2.4% | ||
| Q1 25 | 0.1% | 4.2% | ||
| Q4 24 | 0.0% | 5.0% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | 0.1% | 1.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | -0.54× | ||
| Q3 25 | 1.19× | 3.15× | ||
| Q2 25 | -0.64× | -3.63× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | 6.74× | 0.22× | ||
| Q3 24 | 2.71× | 8.83× | ||
| Q2 24 | — | -10.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
MYFW
| Net Interest Income | $20.9M | 76% |
| Noninterest Income | $6.7M | 24% |
